On Friday, President-elect Donald Trump announced his nominations to lead the CDC, for FDA Commissioner, and for Surgeon ...

The US has not gotten a grade above a C+ since 2013, as the preterm birth rate has gone up almost a whole percentage point in ...

In the US, liraglutide, semaglutide, and tirzepatide are currently under investigation for their ability to stimulate weight ...

With approval, acoramaidis (Attruby; BridgeBio Pharma) becomes the first agent with a label specifying near-complete ...

The increase in the global burden of interstitial lung disease (ILD) and pulmonary sarcoidosis had the greatest impact on ...

Native Hawaiian and non-Hispanic Black individuals had the highest burden of mortality among patients with early-onset ...

For over 20 years, the Movember Foundation has used its mustache-growing campaign to raise awareness and funds for men's ...

A claims-based study revealed high adherence to phosphorodiamidate morpholino oligomer (PMO) treatments for Duchenne muscular dystrophy (DMD), but highlights limitations in interpreting real-world ...

Patients experienced similar safety and efficacy if they received first-line or later-line treatment for unresectable ...

Significant gaps in vaccination coverage among nursing home residents leaves vulnerable populations at risk for severe ...

Patients continued taking their medications for pulmonary arterial hypertension (PAH) when symptoms appeared to improve, ...

The new report is an attempt to provide comprehensive safety data on the rapidly changing treatment landscape for relapsed or ...